Study of the Anti-Inflammatory Effects of Colgate Total® During an Experimental Gingivitis Model
NCT ID: NCT01799226
Last Updated: 2016-01-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2013-03-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluate Inflammation Caused by Gingivitis in Adults
NCT00941668
Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences
NCT07124533
Clinical Investigation of the Effects of Colgate Total Toothpaste as Compared to a Matching Placebo on Periodontal Disease and Systemic Inflammatory Markers
NCT02670135
Compare Anti-inflammatory Dentifrices
NCT00762528
Clinical Study to Assess Therapeutic Delay and Resolution of Induced Gingivitis
NCT05731778
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the induction phase (i.e., day 0 to day 21), participants are instructed to refrain from all hygiene procedures in the stent area. During this time period, participants evenly distributed 2mL of their assigned dentifrice into their stent, allowing it to come into contact with the areas of experimental gingivitis for two minutes twice daily while traditional tooth brushing was performed in the non-stent areas. Clinical measures, saliva, gingival crevicular fluid and plaque samples will be collected at days 0, 14, 21, and 35 study visits. A randomization chart will be used to identify which two sites (teeth and tooth surface) will be used at the specific study visit for collection of gingival crevicular fluid(GCF) and plaque.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Toothpaste without Triclosan
This arm will use a toothpaste that does not contain triclosan
Toothpaste without triclosan
this intervention will use a toothpaste without triclosan
Triclosan
This arm will use colgate total which contains triclosan
Triclosan
this intervention will use Colgate Total which contains triclosan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Toothpaste without triclosan
this intervention will use a toothpaste without triclosan
Triclosan
this intervention will use Colgate Total which contains triclosan
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gender - female or male
* Age - 18 to 40 years old
* Dentition - minimum of 20 permanent teeth
* Probing Pocket Depth of 1-4mm in all sites
* Mean Clinical Attachment Levels of 2mm on all teeth
* Bleeding Upon Probing of greater than 30% at Day -14 Study Visit
* Consent Form - read, understood, and signed
* Study Procedures - willing to follow all study procedures
* BOP less than 10% at the second assessment visit will be exited from the
* study
Exclusion Criteria
* Diseases of the immune system
* Medical condition that may affect outcome (neurologic or psychiatric disorders, systemic infection
* Medications - chronic medications known to affect the periodontal status (calcium antagonists anticonvulsives, immunosuppressives, anti-inflammatory medications, phenytoin, Depo-Provera contraceptive injection users
* New oral contraceptives users within 3 months of baseline or are planning on starting oral contraceptives during the study
* Hypersensitivity - previous known reaction to or oral allergy to any ingredient in the study toothpaste
* Antibiotics - antibiotic therapy within 3 months of baseline visit
* antibiotic therapy needed for infective endocarditis prophylaxis or total joint replacement
* Use of antiseptics - homecare regime using products to control dental plaque formation within 30 days prior to baseline visit
* Smoking - current smokers, smokers who quit smoking less than one year ago, or a pack-year history of more than or equal to 10 (pack-years will be calculated by multiplying the number of years smoked by the average number of cigarette packs smoked per day)
* Continine - positive urine analysis results
* Current Dental Treatment - orthodontic or periodontal treatment
* Untreated Dental Treatment - untreated carious lesions
* Defective restorations which could exacerbate during a period of oral hygiene abstinence
* Pregnant or women breast-feeding
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Janet Kinney
Assistant Professor of Dentistry, Director of Dental Hygiene Program
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janet Kinney, MS
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Michigan Center for Oral Health Research
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pancer BA, Kott D, Sugai JV, Panagakos FS, Braun TM, Teles RP, Giannobile WV, Kinney JS. Effects of triclosan on host response and microbial biomarkers during experimental gingivitis. J Clin Periodontol. 2016 May;43(5):435-44. doi: 10.1111/jcpe.12519. Epub 2016 Apr 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00055445
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.